GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: compound 29 [PMID: 40257122]
Compound class:
Synthetic organic
Comment: DA-302168S is an orally bioavailable small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist [1]. Drugs of this class are proposed for the management of type 2 diabetes and obesity, as an alternative to peptidic GLP-1R agonists.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
DA-302168S is not an agonist at the mouse, rat or canine GLP-1Rs [1]. It is a full agonist of human and monkey receptors in luciferase and cAMP accumulation assays, but its Emax is lower than that of endogenous GLP-1 in a β-arrestin recruitment assay. |
Selectivity at GPCRs | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|